glp 1 drugs and ms LC-MS Characterization of GLP-1 Peptides PDF) Multiple Sclerosis Patients taking
Description
The FDA accepted Novo Nordisks NDA for an oral formulation of Wegovy
Drugs 68 (15), 21312162
Herein, we provide perspectives on the historical events and key experimental findings establishing the biology of GLP-1 as an insulin-stimulating glucoregulatory hormone
Mishra R et al
NAEs were identified using SOC = nervous system disorders (SOC ID: 10,029,205) and primary SOC = Yes, encompassing 1075 PTs from MedDRA version 27.0
doi: 10.1111/dom.14553 [DOI] [PMC free article] [PubMed] [Google Scholar] 45.Farah C, Michel LYM, Balligand JL
